Tecentriq & Avastin (atezolizumab & bevacizumab)
pCPA File Number:
21289
Negotiation Status:
Negotiations were not pursued
Indication(s):
Non-Squamous Non-Small Cell Lung Cancer
Sponsor/Manufacturer:
HOFFMANN-LA ROCHE LIMITED
CADTH Project Number:
pCODR 10155
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: